We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Company news from ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Ferrexpo court dates delayed as operations continue

Mon 25 March 2024 09:10

(Sharecast News) - Ferrexpo updated the market on the proceedings involving its subsidiary Ferrexpo Poltava Mining (FPM) on Monday.

Virgin Wines confident of meeting FY expectations after 'positive' H1

Mon 25 March 2024 08:08

(Sharecast News) - Virgin Wines said on Monday that it was confident of meeting its full-year 2024 profit expectations following a "positive" first-half performance.

Octopus Renewables Infrastructure Trust ups divi despite drop in NAV

Mon 25 March 2024 08:03

(Sharecast News) - Octopus Renewables Infrastructure Trust (ORIT), the clean energy investment fund of Octopus Energy Group, reported a small drop in net asset value in 2023, but still upped its payouts to shareholders after what it deemed a "resilient" p

Pennon trading in line, but bad weather impacts waste-water operations

Mon 25 March 2024 07:36

(Sharecast News) - Water group Pennon said it expects to report full-year results in line with expectations as it makes record levels of investment in the current pricing cycle, though challenging weather conditions have impacted its waste-water operation

Mobico shares slump as Nat Express owner warns on profit

Mon 25 March 2024 07:35

(Sharecast News) - Shares in National Express owner Mobico slumped on Monday after the transport company issued a profit warning and said its annual results would be delayed further due to auditing issues at its German rail business.

Wise appoints new finance chief

Mon 25 March 2024 07:23

(Sharecast News) - Wise announced the appointment of Emmanuel Thomassin as its new chief financial officer and director Monday.

AstraZeneca gets FDA approval for Ultomiris treatment

Mon 25 March 2024 07:23

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Henry Boot predicts brighter future but expects "lag" in performance

Mon 25 March 2024 07:17

(Sharecast News) - UK-listed property developer Henry Boot has said that, while it expects macro conditions to improve this year, the company will see a "lag" in performance with results likely to be weighted to the second half.

Direct Line confident in standalone prospects as Ageas abandons pursuit

Mon 25 March 2024 07:16

(Sharecast News) - Direct Line said on Monday that it was confident in its standalone prospects after Belgium's Ageas announced it would not be making an offer for the insurer following two failed attempts at engaging with the board.

Kingfisher issues profit warning on weaker French DIY market

Mon 25 March 2024 07:04

(Sharecast News) - B&Q owner Kingfisher on Monday warned current-year profit would fall short of expectations after it posted weaker earnings for 2023-24 as the home improvement market continued to lag behind demand for housing.